Elsevier, the world's largest
publisher of
medical and
scientific literature, forms
part of the
Reed Elsevier group.
Based in
Amsterdam
, the company has substantial operations in the
United
Kingdom
, USA
and elsewhere.
Origins
Elsevier took its name (in modernised form) from the historic
Dutch publishing house of the same
name, but which had no connection with the present company.
The
Elzevir family had operated as booksellers and publishers in the
Netherlands
. Its founder, Lodewijk Elzevir, (1542–1617) lived in
Leiden
and established the business in 1580.
Modern company
The modern company was founded in 1880. Leading products include
journals such as
The Lancet and
Cell, books such as
Gray's Anatomy, the
ScienceDirect collection of
electronic journals, as well as the
Trends series, and the
Current Opinion series. More recently
Elsevier has launched the online citation database
Scopus and the free researcher collaboration
tool
2collab.
Elsevier company
It publishes about 250,000 articles per year in 2000 journals. Its
archives contain 7 million past publications. Total yearly
downloads amount to 240 million.
Economic indicators
Elsevier is part of the
Reed Elsevier
group. In terms of
revenue, it accounts for
28% of the total (₤1.5b of 5.4 billions in 2006). In terms of
operating profit,
it represents a much bigger fraction of 44% (₤395 of 880 millions).
Adjusted operating profits have risen by 10% between 2005 and
2006.
| Reed Elsevier Annual Report
2006 |
| Turnover |
€ 7'935 million (+5% from '05) |
| Pre-tax profit |
€ 1'060 million (+3% from '05) |
| Elsevier Annual Report
2006 |
| Turnover |
€ 2'236 million (+6.6% from '05) |
| Pre-tax profit |
€ 581 million (+0.5% from '05) |
| see Elsevier reports; turnover = revenue; profits not
adjusted |
Company figures
7,000 journal editors, 70,000
editorial
board members and 200,000 reviewers are working for Elsevier.
Each year, the company publishes the original work of more than
500,000 authors in 2,000 journals, 17,000 books, 18 new journals
and 1,900 new books.
It is headed by
Chief Executive
Officer (CEO)
Erik Engstrom.
With its
headquarters based in Amsterdam
, Netherlands
, Elsevier employs more than 7,000 people in over 70
offices across 24 countries.
Elsevier's operating divisions
Elsevier has two distinct operating divisions: Science &
Technology and
Health Sciences.
Products and services of both include electronic and print versions
of journals, textbooks and
reference
works and cover the health, life, physical and
social sciences.
Science & Technology
Herman van Campenhout is the
CEO.
The target markets are academic and government research
institutions, corporate research labs, booksellers, librarians,
scientific researchers, authors, and editors.
Flagship products and services include:
VirtualE,
ScienceDirect,
Scopus,
Scirus,
EMBASE,
Engineering Village,
Compendex,
Cell.
There are the following subsidiary imprints, many of them
previously independent publishing companies:
Academic Press,
Architectural Press,
Butterworth-Heinemann,
CMP,
Digital Press,
Elsevier,
Focal Press,
Gulf Professional Publishing,
Morgan Kaufmann, Newnes,
Pergamon Press,
Pergamon Flexible Learning,
Syngress Publishing.
Health Sciences
The target market is physicians, nurses, allied health
professionals, medical and nursing students and schools, medical
researchers,
pharmaceutical
companies, hospitals, and research establishments. Publishing
in 12 languages including English, German, French Spanish, Italian,
Portuguese, Polish, Japanese and Chinese.
Flagship publications include: The 'Consult' series (FirstCONSULT,
PathCONSULT, NursingCONSULT, MDConsult,
StudentCONSULT), Virtual Clinical Excursions,
and major reference works such as
Gray's
Anatomy,
Nelson' Pediatrics,
Dorland's
Illustrated Medical Dictionary,
Netter's Atlas of Human Anatomy, and online
versions of many journals including
The
Lancet etc.
There are the following subsidiary imprints, previously independent
publishing companies:
Saunders,
Mosby,
Churchill Livingstone,
Butterworth-Heinemann,
Hanley & Belfus, Bailliere-Tindall,
Urban & Fischer, Masson.
Criticism and controversies
In recent years the subscription rates charged by the company for
its journals have been criticised; some very large journals (those
with more than 5000 articles) charge subscription prices as high as
$14,000, far above average. The company has been criticised not
just by advocates of a switch to the so-called
open-access publication model, but
also by universities whose library budgets make it difficult for
them to afford current journal prices.
For example, a
resolution by Stanford
University
's senate singled out Elsevier as an example of a
publisher of journals which might be "disproportionately expensive
compared to their educational and research value" and which
librarians should consider dropping, and encouraged its faculty
"not to contribute articles or editorial or review efforts to
publishers and journals that engage in exploitive or exorbitant
pricing". Similar guidelines and criticism of
Elsevier's pricing policies have been passed by the University of California, Harvard
University
and Duke University
. The elevated pricing of field journals in
economics, most of which are published by Elsevier, was one of the
motivations that moved the
American Economic Association
to launch the
American
Economic Journal in 2009.
Resignation of editorial boards
In November 1999 the entire Editorial Board (50 persons in total)
of the
Journal of Logic
Programming (founded in 1984 by
Alan Robinson) collectively resigned
after 16 months of unsuccessful negotiations with Elsevier Press
about the price of library subscriptions. This editorial board
created a new journal (
Theory and Practice of
Logic Programming) with
Cambridge University Press at a
much lower price, and on its side Elsevier continued the
publication of the journal with a completely different editorial
board and a slightly different name (the
Journal of Logic and
Algebraic Programming).
In 2002, dissatisfaction at Elsevier's pricing policies caused the
European Economic
Association to terminate an agreement with Elsevier which
designated Elsevier's
European
Economic Review as the official journal of the association. The
EEA decided to launch a new journal, the
Journal of the
European Economic Association.
At the end of 2003, the entire editorial board of the prestigious
Journal of Algorithms
resigned to start
ACM
Transactions on Algorithms with a different, lower priced
publisher, at the suggestion of
Journal of Algorithms
founder
Donald Knuth.
The same happened in 2005 to the
International
Journal of Solids and Structures whose editors resigned to
start the
Journal of
Mechanics of Materials and Structures.
However, a new
editorial board was quickly established and the journal continues
in apparently unaltered form with Editors Prof Hills from Oxford
and Dr. Stelios Kyriakides from
the University of
Texas at Austin
.
On
August 10,
2006,
the entire editorial board of the distinguished
mathematical journal Topology handed in their
resignation, again because of stalled negotiations with Elsevier to
lower the subscription price. This board has now launched the new
Journal of Topology at a far
lower price, under the auspices of the
London Mathematical
Society.
The French
École Normale Supérieure
has stopped having Elsevier publish the prestigious
journal Annales
Scientifiques de l'École Normale Supérieure (as of
2008).
Parent organisation links to weapons industry
An editorial in the
medical journal
The Lancet in September 2005
sharply criticized the journal's owner and publisher, Reed
Elsevier, for its participation in the international
arms trade. Specifically, Reed Exhibitions
organized the
Defence
Systems and Equipment International Exhibition (DSEi), a large
arms fair in the U.K. The authors, appealing to the
Hippocratic oath called for the publisher
to
divest itself of all business interests that threaten human,
and especially civilian, health and well-being.
In the
March 2007 issue of the The Lancet, leading
medical centers including the UK Royal College
of Physicians
urged Reed Elsevier to sever weapons ties.
Doctors spoke out against Reed's role in the involvement of the
organizing of exhibitions for the arms trade. Reed Elsevier’s chief
executive responded in June 2007 with a written statement agreeing
to do so , welcomed by authors of the petition, announcing that it
would sell the part of the company which handled military
trade shows. The sale was completed in May
2008.
Chaos, Solitons and Fractals
There has been some recent controversy over the journal
Chaos, Solitons and
Fractals. There is speculation that the editor-in-chief,
M. El Naschie, is misusing his power to publish his work, without
peer review. The journal has published 322 papers with El Naschie
as author since 1993. The last issue in December 2008 featured 5 of
his papers. The controversy has been covered extensively in the
blogosphere. According to the journal's website, El Naschie was
replaced as editor-in-chief beginning January, 2009.
Fake journals
At a 2009 court case in Australia where
Merck & Co. is being sued by a user of
Vioxx, the plaintiff alleged that Merck had
paid Elsevier to publish the
Australasian
Journal of Bone and Joint Medicine, which had the
appearance of being a
peer-reviewed
academic journal but in fact
contained only articles favourable to Merck drugs. Merck has
described the
Australasian Journal of Bone and Joint
Medicine as a "complimentary publication", denied claims that
articles within it were
ghost written
by Merck, and stated that the articles were all
reprinted from peer-reviewed medical journals. In
May 2009, Elsevier released a statement by Michael Hansen regarding
the
Australasian Journal of Bone and Joint Medicine,
conceding that these were "sponsored article compilation
publications, on behalf of pharmaceutical clients, that were made
to look like journals and lacked the proper disclosures." The
statement further acknowledges that this "was an unacceptable
practice." Also in May 2009,
The
Scientist reports that according to an Elsevier
spokesperson, there were five further sponsored publications that
"were put out by their Australia office and bore the Excerpta
Medica imprint from 2000 to 2005," namely the "
Australasian
Journal of General Practice, the
Australasian Journal of
Neurology, the
Australasian Journal of Cardiology,
the
Australasian Journal of Clinical Pharmacy, the
Australasian Journal of Cardiovascular Medicine".
Excerpta Medica is a "strategic medical communications
agency" run by Elsevier, according to the imprint's web page.
Shill reviews
Elsevier has been accused of offering Amazon gift certificates to
academics who would write positive reviews at
Amazon.com and
Barnes & Noble of their textbook
Clinical Psychology. The company admitted that it had been
a mistake and blamed a "rogue employee" for this practice.
Imprints
Imprints are
brand
names in publishing. Elsevier uses its imprints to market to
different consumer segments. Many of them have previously been the
company names of publishers that were purchased by Reed
Elsevier.
References
- Elsevier at a glance
- http://www.elsevier.com/wps/find/intro.cws_home/glance_1
(accessed 19 October 2007)
- Reed Elsevier | Annual Report and Financial
Statements 2006
- Reed Elsevier | Annual Report and Financial
Statements 2006
- Elsevier
- Elsevier
- Faculty Senate minutes February 19 meeting
Stanford Report, Feb. 25, 2004
- David Glenn. "American Economic Association Plans 4 New
Journals". The Chronicle of Higher Education. January 25,
2008. Available online at
http://chronicle.com/article/American-Economic-Association/440
- Joan Birman:
Scientific Publishing: A Mathematician’s
Viewpoint Notices of the AMS, Vol. 47, No. 7,
August 2000
- The EEA's Journal: A Brief History
- Changes at the Journal of Algorithms
- Journal of Topology (pub. London Mathematical
Society)
- John Baez:
What We Can Do About Science Journals August 13,
2007
- Ben Goldacre, "The danger of drugs … and data", The
Guardian, 9 May 2009
- Finlo Rohrer, "The perils of five-star reviews", BBC News
Magazine, June 25, 2009. Available online at
http://news.bbc.co.uk/go/pr/fr/-/2/hi/uk_news/magazine/8118577.stm
External links
Web sites pertaining to the company:
Non-Elsevier web sites: